- Chart Art
- Posts
- Stocktwits Chart Art: March 24, 2025
Stocktwits Chart Art: March 24, 2025
The best charts and trade ideas from the day.
STOCKTWITS CHART ART: MARCH 24, 2025
The Stocktwits Summary 📝
The U.S stock market found some momentum, opening higher and continuing to drift higher throughout the day. Beaten-down stocks caught a major bid alongside big tech on reports that Trump’s tariffs will be less severe than anticipated. Traders continue to scour for setups to make the best of this newfound momentum. 👀
Here’s how the major indexes ended the day:
Index | ST Sentiment Score | ST Message Volume |
---|---|---|
$SPY (+1.79%) | Bullish (73) | Low (43) |
$QQQ (+2.19%) | Extremely Bullish (75) | Low (42) |
$IWM (+2.49%) | Bullish (57) | Low (31) |
$DIA (+1.40%) | Bullish (67) | Low (43) |
*The ST Sentiment Score & Message Volume scales range from 0 to 100 (extremely bearish to extremely bullish). More info here.
CHART OF THE DAY
Life Time Group Held Up Well & Breaks Out 📈
$LTH: not easy finding quality setups here but this is a beauty! From the @InvestorsBusinessDaily Leaderboard. Seasonal tailwinds and relative tariff-free play. #IBDPartner
Found using @MarketSurge— Dr. Stoxx (@Dr_Stoxx)
2:51 PM • Mar 24, 2025
Lemonade Looks To Break Out Again 🍋
$LMND - another insurance stock that experienced a huge drawdown during the 2022 bear market: from $190 to $10. Now, it is consolidating in a tight range. Needs to clear $40 to resume its upside momentum.
— ivanhoff (@ivanhoff)
5:33 PM • Mar 24, 2025
Gold Mining Stocks Retest Their Breakout ⛏️
$GDX$NUGT$GDXU$GOLD: miners hit new 52wk highs 5 days ago. Low volume pullback since then. 55 the key level. #IBDPartner @InvestorsBusinessDaily
Chart analysis by @MarketSurge— Dr. Stoxx (@Dr_Stoxx)
11:12 PM • Mar 24, 2025
SPONSORED
Step Up Your Stock Research with MarketSurge! 🕵️
Not getting enough from free charts and websites? MarketSurge is the only platform that puts pro-level tools and research in the hands of individual traders like you. Power your portfolio today with a 6-week trial for just $49.95.
*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.